Using Inotropic and Vasodilating Agents in Pediatric Patients with Cardiac Disease

Delgizzi, Linda J.; Ueda, Julia N.

doi:10.4037/15597768-1990-1013

Article navigation

Advances in Cardiac Care| May 01 1990

Using Inotropic and Vasodilating Agents in Pediatric Patients with Cardiac Disease

Linda J. Delgizzi, RN, MN;

Linda J. Delgizzi, RN, MN

*From the Pediatric Cardiology Division, UCLA Medical Center, Los Angeles, California.

Reprint requests to Linda DelGizzi, 21243 Mulholland Drive, Woodland Hills, CA 91364.

Search for other works by this author on:

This Site

PubMed

Google Scholar

Julia N. Ueda, RN, MN

†From the Divisions of Pediatric Cardiology and Cardiothoracic Surgery, UCLA Medical Center, Los Angeles, California.

Search for other works by this author on:

This Site

PubMed

Google Scholar

AACN Adv Crit Care (1990) 1 (1): 131–147.

https://doi.org/10.4037/15597768-1990-1013

Inotropic and vasodilating agents are traditionally used with diuretics to manage heart failure in children with congenital heart disease. This article reviews the developmental aspects of cardiovascular physiology and the rational use of therapeutic agents for acutely ill surgical and medical pediatric patients with cardiac disease. By understanding the actions and indications for inotropic support and afterload reduction, the critical care nurse can intelligently administer these agents and evaluate their effects.

This content is only available as a PDF.

1990

You do not currently have access to this content.

Don't already have an account? Register

Using Inotropic and Vasodilating Agents in Pediatric Patients with Cardiac Disease

Cited By

Email alerts

JOURNALS

Using Inotropic and Vasodilating Agents in Pediatric Patients with Cardiac Disease

Sign in

AACN Account

Sign in via your Institution

Subscribe

Short-term Access

Cited By

Email alerts

JOURNALS

This Feature Is Available To Subscribers Only